Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This phase II study will evaluate the effect of bevacizumab, capecitabine and oxaliplatin
with radiation on rectal cancer. Researchers will also evaluate the tolerability (how it
makes the patient feel) and safety of this combination by watching for harmful
side-effects.It is hoped that by adding bevacizumab to the capecitabine/oxaliplatin treatment
in combination with radiation before surgery will improve response rate.